Single-cell image-based screens identify host regulators of Ebola virus infection dynamics
- PMID: 40707832
- DOI: 10.1038/s41564-025-02034-3
Single-cell image-based screens identify host regulators of Ebola virus infection dynamics
Abstract
Filoviruses such as Ebola virus (EBOV) give rise to frequent epidemics with high case fatality rates while therapeutic options remain limited. Earlier genetic screens aimed to identify potential drug targets for EBOV relied on systems that may not fully recapitulate the virus life cycle. Here we applied an image-based genome-wide CRISPR screen to identify 998 host regulators of EBOV infection in 39,085,093 cells. A deep learning model associated each host factor with a distinct viral replication step. From this we confirmed UQCRB as a post-entry regulator of EBOV RNA replication and show that small-molecule UQCRB inhibition reduced virus infection in vitro. Using a random forest model, we found that perturbations on STRAP (a spliceosome-associated factor) disrupted the equilibrium between viral RNA and protein. STRAP was associated with VP35, a viral RNA processing protein. This genome-wide screen coupled with 12 secondary screens including validation experiments with Sudan and Marburg virus, presents a rich resource for host regulators of virus replication and potential targets for therapeutic intervention.
© 2025. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: P.C.B. is a consultant to or holds equity in 10X Genomics, General Automation Lab Technologies/Isolation Bio, Next Gen Diagnostics, Cache DNA, Concerto Biosciences, Stately, Ramona Optics, Bifrost Biosystems, and Amber Bio. His laboratory received research funding from Calico Life Sciences, Merck, and Genentech for work related to genetic screening. N.H. holds equity in and advises Danger Bio/Related Sciences, owns equity in BioNtech and receives research funding from Bristol Myers Squibb. C.U. serves on the Scientific Advisory Board of Immunai, Relation Therapeutics, and Focal Biosciences, and receives research funding from AstraZeneca and Janssen Pharmaceuticals. The Broad Institute and MIT may seek to commercialize aspects of this work, and related applications for intellectual property have been filed. A.S. is an employee at Genentech and R.J.C. is an employee at Flagship Pioneering. The remaining authors declare no competing interests.
Update of
-
Single-cell image-based genetic screens systematically identify regulators of Ebola virus subcellular infection dynamics.bioRxiv [Preprint]. 2024 Apr 7:2024.04.06.588168. doi: 10.1101/2024.04.06.588168. bioRxiv. 2024. Update in: Nat Microbiol. 2025 Aug;10(8):1989-2002. doi: 10.1038/s41564-025-02034-3. PMID: 38617272 Free PMC article. Updated. Preprint.
References
-
- Hoenen, T., Groseth, A. & Feldmann, H. Therapeutic strategies to target the Ebola virus life cycle. Nat. Rev. Microbiol. 17, 593–606 (2019). - PubMed
MeSH terms
Substances
Grants and funding
- 1DP2AT012345/U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (NCCIH)
- HG006193/U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI)
- P01AI120943/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- HG009283/U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI)
- 01/Hertz Foundation (Fannie and John Hertz Foundation)
- 01/NSF | Directorate for Education & Human Resources | Division of Graduate Education (DGE)
- RM1 HG006193/HG/NHGRI NIH HHS/United States
- Career Award/Burroughs Wellcome Fund (BWF)
- N00014-22-1-2116/United States Department of Defense | United States Navy | Office of Naval Research (ONR)
- P01AI120943./U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
LinkOut - more resources
Full Text Sources
Medical
